In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
Month: March 2026
Another mess for Natalizumab biosimilar use
Tweet The documents that dictate how a drug is used is called the “label” or the “summary of product characteristics” in Europe or UK. Yesterday, there was a post about biosimilar natalizumab (Tyruko) and reference natailizumab (Tysabri). In the highlights of the paper ( Gelissen et al. Mult Scler Relat Disord. 2026;109:107147. It said •Discrepant…
Me-Too Natalizumab…. Does Holland have the West London Feeling?
Tweet When the patent of reference natalizumab (Tysabri) infusion ran out the makers brought out subcutaneous natalizumab (Tysabri) and encouraged the neuros to switch…It also allowed generic makers to make replicas of natalizumab, called a biosimilar because it isn’t identical. Along came the first biosimilar natalizumab (Tyruko) and NICE in their stupidity said switch every…
I trusted my gut, even after hearing I was ‘too young’ to have MS
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
I regained the confidence to travel after my MS diagnosis
In recognition of Multiple Sclerosis Awareness Month in March, the MS Community Spotlight campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSSpotlight, or read the full series….
The Crap Gap with Natalizumab..No clues
Tweet The wearing off effect also known to some as the “CRAP gap” is something that occurs when you get to the end of your treatment cycle. But what is it? AI says “The “wearing-off” effect (WOE) of monoclonal antibodies (MAbs) is a commonly reported phenomenon where therapeutic benefits subside before the next dose is…
Common anti-aging drugs may damage brain’s protective coating
A combination of drugs widely used in anti-aging studies seems to compromise the function of the brain’s myelin-making cells and cause profound myelin loss, according to the findings of a new study in mice and lab-grown cells. The dual treatment, which combines dasatinib and quercetin, also known as D+Q, caused oligodendrocytes — the cells that…
Autoabogacía en acción: Aprendiendo de quienes viven con EM
Al trabajar en la Asociación de Esclerosis Múltiple de América (MSAA, por sus siglas en inglés), a menudo me preguntan si tengo un diagnóstico de esclerosis múltiple (EM). Aun cuando la EM no forma parte de mi historia personal, convivir … Continue reading → Source: blog.mymsaa.org
Advocacy in Action: Learning from People with MS
Working at the Multiple Sclerosis Association of America (MSAA), I am often asked if I have a diagnosis of multiple sclerosis (MS). While MS is not part of my personal journey, speaking with people living with MS has given me … Continue reading → Source: blog.mymsaa.org
My MS diagnosis opened a window to a whole new world
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….